Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V9JS
|
||||
Former ID |
DNC011461
|
||||
Drug Name |
3-(1,1-Dimethyl-2-phenyl-ethyl)-pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C15H17N
|
||||
Canonical SMILES |
CC(C)(CC1=CC=CC=C1)C2=CN=CC=C2
|
||||
InChI |
1S/C15H17N/c1-15(2,14-9-6-10-16-12-14)11-13-7-4-3-5-8-13/h3-10,12H,11H2,1-2H3
|
||||
InChIKey |
MSUUKPGKCBHOAJ-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 11B1, mitochondrial | Target Info | Inhibitor | [1] | |
BioCyc Pathway | Superpathway of steroid hormone biosynthesis | ||||
Glucocorticoid biosynthesis | |||||
Mineralocorticoid biosynthesis | |||||
KEGG Pathway | Steroid hormone biosynthesis | ||||
Metabolic pathways | |||||
PathWhiz Pathway | Steroidogenesis | ||||
Reactome | Glucocorticoid biosynthesis | ||||
Endogenous sterols | |||||
WikiPathways | Metapathway biotransformation | ||||
Oxidation by Cytochrome P450 | |||||
Metabolism of steroid hormones and vitamin D | |||||
Corticotropin-releasing hormone | |||||
References | |||||
REF 1 | J Med Chem. 1984 Jan;27(1):15-9.Structure-activity relationship study of the inhibition of adrenal cortical 11 beta-hydroxylase by new metyrapone analogues. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.